Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial.
Takao TakeshimaMika KomoriYuka TanjiAkichika OzekiYoshihisa TatsuokaPublished in: Advances in therapy (2022)
Although few interactions were observed, lasmiditan could be a promising acute treatment option in a wide range of Japanese patients with migraine, as efficacy is not generally influenced by patient and migraine characteristics.